New drugs and regimens for tuberculosis

KC Chang, E Nuermberger, G Sotgiu, CC Leung - Respirology, 2018 - Wiley Online Library
Since standardized rifampin‐based first‐line regimens and fluoroquinolone‐based second‐
line regimens were used to treat tuberculosis (TB), unfortunately without timely modification …

[HTML][HTML] Health-related quality of life based on EQ-5D utility score in patients with tuberculosis: a systematic review

HY Park, HB Cheon, SH Choi, JW Kwon - Frontiers in Pharmacology, 2021 - frontiersin.org
Background: Tuberculosis (TB) has significant effects on patients' health-related quality of
life (HRQOL) and this study was conducted to evaluate the HRQOL based on EQ-5D utility …

[HTML][HTML] Фармакоэпидемиология и фармакоэкономика туберкулеза с множественной и широкой лекарственной устойчивостью возбудителя

НЮ Николенко, ДА Кудлай… - Фармакоэкономика …, 2021 - cyberleninka.ru
Лечение туберкулеза (ТБ) с множественной (МЛУ) и широкой лекарственной
устойчивостью (ШЛУ) возбудителя является актуальной проблемой во всем мире. В …

[HTML][HTML] Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany

D Wirth, R Dass, R Hettle - BMC Health Services Research, 2017 - Springer
Background Treatment of multidrug-resistant tuberculosis (MDR-TB) is complex, lengthy,
and involves a minimum of four drugs termed a background regimen (BR), that have not …

Pharmacoepidemiology and pharmacoeconomics of multidrug-and extensively drug-resistant tuberculosis

NY Nikolenko, DА Kudlay… - …, 2021 - pharmacoeconomics.ru
Abstract Treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR)
tuberculosis (TB) is a current problem worldwide. Currently, special attention is paid to the …

Перспективы применения таргетной химиотерапии деламанидом в схемах лечения больных туберкулезом с множественной/широкой лекарственной …

АГ Наумов, АВ Павлунин - Туберкулез и болезни легких, 2018 - tibl-journal.com
Аннотация Представлен обзор современных статей, клинических рекомендаций и
руководств (гайдлайнов) зарубежных авторов, посвященных проблеме лечения …

Delamanid and bedaquiline–A review on analytical methods determined with recent updates on pharmacokinetics, pharmacodynamics, and drug-drug interaction

K Sethy, K Raja Rajeswari… - The Thai Journal of …, 2024 - digital.car.chula.ac.th
Delamanid and bedaquiline are recently approved drugs for the treatment of multi-drug
resistance tuberculosis (TB). It was found that the concomitant use of both drugs helped in …

Perspectives of targeted chemotherapy with delamanid in the treatment regimens of those with multiple/extensive drug resistant tuberculosis. A success, chance or …

AG Naumov, AV Pavlunin - Tuberculosis and Lung Diseases, 2018 - tibl-journal.com
The article presents the review of current publications, clinical recommendations and
guidelines written by foreign authors and devoted to treatment of drug resistant tuberculosis …

Effect of quantitative intraocular pressure reduction on visual field defect progression in normal tension glaucoma under medical therapy applying Markov model

K Yoshikawa, K Santo, H Hizaki… - Clinical …, 2018 - Taylor & Francis
Purpose To quantitatively evaluate the association of intraocular pressure (IOP) reduction
with visual field defect (VFD) progression in normal tension glaucoma (NTG) under medical …

[PDF][PDF] ФГБОУ ВО «Приволжский исследовательский медицинский университет» МЗ РФ, г. Нижний Новгород, Россия

АГ НАУМОВ, АВ ПАВЛУНИН - ТУБЕРКУЛЁЗ И БОЛЕЗНИ …, 2018 - tibl-journal.com
Представлен обзор современных статей, клинических рекомендаций и руководств
(гайдлайнов) зарубежных авторов, посвященных проблеме лечения туберкулеза с …